Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

CUSIP: 47103J105

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 6 signals
Share change
+525,329
SEC-reported price per share
$12.21
Number of holders
43
Value change
+$6,297,905
Number of buys
17
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,419,303

Security key

47103J105

Report period

Q2 2022

Institutions

43

Top holders

10

Ownership snapshot

Top reported holders of JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bregua Corp
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5 13F Highest disclosed value: $124,337,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $124.34M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
Bregua Corp $22.01M
RA CAPITAL MANAGEMENT, L.P. $124.34M
FMR LLC $81.41M
ORBIMED ADVISORS LLC $40.67M
Janus Henderson Group Ltd. $33.54M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bregua Corp
3/4/5
10%+ Owner
—
denominator unverified
$22,008,098
3,749,250 shares
— 15 Jun 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$124,337,000
8,670,644 shares
— 31 Mar 2022
FMR LLC
13F
Company
13F
—
denominator unverified
$81,407,000
5,676,922 shares
— 31 Mar 2022
ORBIMED ADVISORS LLC
13F 3/4/5
Company · Director
—
denominator unverified
$40,674,000
2,836,386 shares
— 31 Mar 2022
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$33,542,000
2,339,146 shares
— 31 Mar 2022
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$26,578,000
1,853,432 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
43
Shares
28,911,820
Rows available
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
46
Q2 2022 holders
43
Holder diff
-3
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .